arrow
返回
B

Bart Maes

Pontificia Universidade Catolica do Parana

69H指数
355论文数
1.4W被引数
收录论文 66
发表时间
Iptacopan in patients with IgA nephropathy from East AsiaIptacopan在东亚IgA肾病患者的应用
err2025-11-07
err0
errOAAI
errHong Zhang; Vlado Perkovic; Jonathan Barratt; Dana V. Rizk; Brad Rovin; Hernán Trimarchi; Bart Maes; Tobias Merkel; Manasi Desai; Soudeh Ansari; Ronny Renfurm; Thomas Hach; Naoki Kashihara
err分享
err收藏
A meta-analysis of albuminuria as a surrogate endpoint for kidney failure白蛋白尿作为终末期肾病替代终点的荟萃分析
err2025-11-06
err0
PREAI
errHiddo J. L. Heerspink; Willem H. Collier; Juhi Chaudhari; Shiyuan Miao; Hocine Tighiouart; Gerald B. Appel; Fernando Caravaca-Fontán; Jürgen Floege; Thierry Hannedouche; Enyu Imai; Tazeen H. Jafar; Julia B. Lewis; Philip K. T. Li; Francesco Locatelli; Bart D. Maes; Brendon L. Neuen; Vlado Perkovic; Ronald D. Perrone; Giuseppe Remuzzi; Francesco P. Schena; Christoph Wanner; Tom Greene; Lesley A. Inker
err分享
err收藏
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy
err2025-11-01
err5
PREAI
errLafayette, Richard; Barbour, Sean J.; Brenner, Robert M.; Campbell, Kirk N.; Doan, Tom; Eren, Necmi; Floege, Jurgen; Jha, Vivekanand; Kim, Beom Seok; Liew, Adrian; Maes, Bart; Pal, Atanu; Pecoits-Filho, Roberto; Phoon, Richard K. S.; Rizk, Dana V.; Suzuki, Hitoshi; Tesar, Vladimir; Trimarchi, Hernan; Wei, Xuelian; Zhang, Hong; Barratt, Jonathan
err分享
err收藏
A mechanistic biopsy study of the effect of iptacopan on immunopathology in patients with IgA nephropathy (IgAN)iptacopan对IgA肾病(IgAN)患者免疫病理学影响的机制性活检研究
err2025-10-01
err0
errOAAI
errRizk, Dana; Maes, Bart; Zhang, Hong; Kretzler, Matthias; Eitner, Frank; Abner, Clint; Valentin, Marie-Anne; Vipin, N.; Di Tata, Maria Fernanda; Barratt, Jonathan
err分享
err收藏
ORIGIN 2b: changes in Gd-IgA1 and eGFR after discontinuation of atacicept treatment in IgA nephropathyORIGIN 2b:在IgA肾病中停止阿他西普治疗后的Gd-IgA1和eGFR变化
err2025-10-01
err0
errOAAI
errBarratt, Jonathan; Barbour, Sean; Brenner, Robert; Eren, Necmi; Floege, Jurgen; Jha, Vivekanand; Kim, Sung Gyun; Maes, Bart; Phoon, Richard; Singh, Harmeet; Tesar, Vladimir; Lafayette, Richard
err分享
err收藏
Origin 3 study design: a global, randomized, controlled, Phase 3 study of atacicept in IgA nephropathyOrigin 3研究设计:一项关于atacicept在IgA肾病中的全球性、随机化、对照性III期研究
err2025-10-01
err0
PREAI
errLafayette, Richard; Maes, Bart; Brenner, Robert; Khawaja, Zeeshan; Floege, Jurgen; Jha, Vivekanand; Tesar, Vladimir; Zhang, Hong; Barbour, Sean; Suzuki, Hitoshi; Trimarchi, Hernan; Barratt, Jonathan
err分享
err收藏
The prevalence of immunoglobulin A nephropathy in the European Union and the impact of the COVID-19 pandemic: an estimation approach utilizing the kidney biopsy frequency
err2025-04-01
err0
errOAAI
errBuisker, Jocelyn; Behr, Sigrid; Kubesch, Nadine Janet; Turkson, Moise E.; Maes, Bart; Kollins, Dmitrij; Webb, Nicholas J. A.; Floege, Jurgen
err分享
err收藏
A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy
err2024-06-01
err17
errOAAI
errLafayette, Richard; Barbour, Sean; Israni, Rubeen; Wei, Xuelian; Eren, Necmi; Floege, Juergen; Jha, Vivekanand; Kim, Sung Gyun; Maes, Bart; Phoon, Richard K. S.; Singh, Harmeet; Tesar, Vladimir; Lin, Celia J. F.; Barratt, Jonathan
err分享
err收藏
Hypouricaemia in a patient with hereditary xanthinuria type I
errLANCET
IF88.5
err2024-04-01
err0
PREAI
errMaes, Bart; Dedeurwaerdere, Franceska
err分享
err收藏
Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy一项随机双盲安慰剂对照2期研究的结果表明,iptacopan可作为IgA肾病的替代补体途径抑制剂
err2024-01-01
err34
errOAAI
errZhang, Hong; Rizk, Dana, V; Perkovic, Vlado; Maes, Bart; Kashihara, Naoki; Rovin, Brad; Trimarchi, Hernan; Sprangers, Ben; Meier, Matthias; Kollins, Dmitrij; Papachristofi, Olympia; Milojevic, Julie; Junge, Guido; Nidamarthy, Prasanna Kumar; Charney, Alan; Barratt, Jonathan
err分享
err收藏
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
errLANCET
IF88.5
err2023-12-01
err75
PREAI
errRovin, Brad H.; Barratt, Jonathan; Heerspink, Hiddo J. L.; Alpers, Charles E.; Bieler, Stewart; Chae, Dong-Wan; Diva, Ulysses A.; Floege, Juergen; Gesualdo, Loreto; Inrig, Jula K.; Kohan, Donald E.; Komers, Radko; Kooienga, Laura Ann; Lafayette, Richard; Maes, Bart; Malecki, Robert; Mercer, Alex; Noronha, Irene L.; Oh, Se Won; Peh, Chen Au; Praga, Manuel; Preciado, Priscila; Radhakrishnan, Jai; Rheault, Michelle N.; Rote, William E.; Tang, Sydney C. W.; Tesar, Vladimir; Trachtman, Howard; Trimarchi, Hernan; Tumlin, James A.; Wong, Muh Geot; Perkovic, Vlado
err分享
err收藏
A meta-analysis of GFR slope as a surrogate endpoint for kidney failureGFR斜率作为肾衰竭替代终点的荟萃分析
err2023-06-17
err45
PREAI
errInker, Lesley; Collier, Willem; Greene, Tom; Miao, Shiyuan; Chaudhari, Juhi; Appel, Gerald; Badve, Sunil; Caravaca-Fontan, Fernando; Del Vecchio, Lucia; Floege, Juergen; Goicoechea, Marian; Haaland, Benjamin; Herrington, William; Imai, Enyu; Jafar, Tazeen H.; Lewis, Julia; Li, Philip K. T.; Maes, Bart; Neuen, Brendon; Perrone, Ronald; Remuzzi, Giuseppe; Schena, Francesco; Wanner, Christoph; Wetzels, Jack F. M.; Woodward, Mark; Heerspink, Hiddo J. L.
err分享
err收藏
Targeting the Alternative Complement Pathway With Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN Study以Iptacopan靶向替代补体途径治疗IgA肾病: apprause-IgAN研究的设计和原理
err2023-05-01
err28
errOAAI
errRizk, Dana, V; Rovin, Brad H.; Zhang, Hong; Kashihara, Naoki; Maes, Bart; Trimarchi, Hernan; Perkovic, Vlado; Meier, Matthias; Kollins, Dmitrij; Papachristofi, Olympia; Charney, Alan; Barratt, Jonathan
err分享
err收藏
Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKD
err2023-01-19
err6
errOAAI
errCollier, Willem; Inker, Lesley A.; Haaland, Benjamin; Appel, Gerald B.; Badve, Sunil V.; Caravaca-Fontan, Fernando; Chalmers, John; Floege, Jurgen; Goicoechea, Marian; Imai, Enyu; Jafar, Tazeen H.; Lewis, Julia B.; Li, Philip K. T.; Locatelli, Francesco; Maes, Bart D.; Neuen, Brendon L.; Perrone, Ronald D.; Remuzzi, Giuseppe; Schena, Francesco P.; Wanner, Christoph; Heerspink, Hiddo J. L.; Greene, Tom
err分享
err收藏
Clinicopathological characteristics and disease chronicity in native kidney biopsies in Flanders
err2022-09-14
err1
errOAAI
errDeleersnijder, Dries; Laurens, Wim; De Meester, Johan; Cleenders, Evert; Dendooven, Amelie; Lerut, Evelyne; De Vriese, An S.; Dejagere, Tom; Helbert, Mark; Hellemans, Rachel; Koshy, Priyanka; Maes, Bart; Pipeleers, Lissa; Van Craenenbroeck, Amaryllis H.; Van Laecke, Steven; Vande Walle, Johan; Couttenye, Marie M.; Meeus, Gert; Sprangers, Ben
err分享
err收藏
Epidemiology of native kidney disease in Flanders: results from the FCGG kidney biopsy registry
err2022-01-29
err12
errOAAI
errLaurens, Wim; Deleersnijder, Dries; Dendooven, Amelie; Lerut, Evelyne; De Vriese, An S.; Dejagere, Tom; Helbert, Mark; Hellemans, Rachel; Koshy, Priyanka; Maes, Bart; Pipeleers, Lissa; Van Craenenbroeck, Amaryllis H.; Van Laecke, Steven; Vande Walle, Johan; Coutteneye, Marie M.; De Meester, Johan; Sprangers, Ben
err分享
err收藏
Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysisIgA肾病早期尿蛋白变化与GFR斜率治疗效果的关系: 一项个体参与者的Meta分析
err2021-09-01
err33
PREAI
errInker, Lesley A.; Heerspink, Hiddo J. L.; Tighiouart, Hocine; Chaudhari, Juhi; Miao, Shiyuan; Diva, Ulysses; Mercer, Alex; Appel, Gerald B.; Donadio, James, V; Floege, Jurgen; Li, Philip K. T.; Maes, Bart D.; Locatelli, Francesco; Praga, Manuel; Schena, Francesco P.; Levey, Andrew S.; Greene, Tom
err分享
err收藏
Observational study on the incidence of nephrogenic systemic fibrosis in patients with renal impairment following gadoterate meglumine administration: the NSsaFe study.
err2019-07-09
err12
PREAI
errMcWilliams, Richard G.; Frabizzio, Jennifer, V; De Backer, Adelard, I; Grinberg, Anna; Maes, Bart D.; Zobel, Bruno Beomonte; Gottschalk, Andreas
err分享
err收藏
err分享
err收藏